Profile

Hi everyone, I'd love to hear what everyone is doing for tarlatamab monitoring right now. It's an ever-evolving process for us at the moment. Outpatient administration + monitoring for C1D1+D8 is reserved for our ECOG 0-1, lower disease burden, no active CNS disease. We administer at 5PM on a Wednesday ...

Hi Kevin! My docs were just SO excited about this data. It is certainly interesting.... but a logistical nightmare from my perspective. What do you think? Lia ------------------------------ Lia Lynch, PharmD, BCOP Clinical Pharmacist, Thoracic Oncology UVA Health --------------------------- ...